Change in LRAGG in response to IFN Treatment in patients with liver fibrosis.

<p>(A) The change in the level of LRAGG in patients who responded to IFN and cleared their HCV and had low LRAGG at start of treatment. As this figure shows, there is no significant change in patients who started with low levels of LRAGG in response to IFN therapy. (B) In contrast, those patients who responded to IFN and cleared their HCV and started had greater than 5-fold increase over normal at the start of treatment show a significant decrease following treatment (P<0.05) (C). However, patients who do not respond to IFN treatment show a significant increase (P<0.05) following treatment when they began with low levels (C) and stayed high when they started with greater than 5-fold increase in LRAGG over normal (D).